Arrowroot Family Office LLC Purchases Shares of 11,337 iShares Biotechnology ETF $IBB

Arrowroot Family Office LLC purchased a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 11,337 shares of the financial services provider’s stock, valued at approximately $1,434,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Citigroup Inc. raised its position in shares of iShares Biotechnology ETF by 88.5% in the 1st quarter. Citigroup Inc. now owns 3,208,144 shares of the financial services provider’s stock valued at $410,322,000 after purchasing an additional 1,505,976 shares during the last quarter. Commonwealth Equity Services LLC raised its position in shares of iShares Biotechnology ETF by 12.0% in the 1st quarter. Commonwealth Equity Services LLC now owns 194,516 shares of the financial services provider’s stock valued at $24,879,000 after purchasing an additional 20,915 shares during the last quarter. Jones Financial Companies Lllp raised its position in shares of iShares Biotechnology ETF by 763.3% in the 1st quarter. Jones Financial Companies Lllp now owns 151,265 shares of the financial services provider’s stock valued at $19,347,000 after purchasing an additional 133,744 shares during the last quarter. Generali Investments CEE investicni spolecnost a.s. raised its position in shares of iShares Biotechnology ETF by 35.0% in the 2nd quarter. Generali Investments CEE investicni spolecnost a.s. now owns 116,115 shares of the financial services provider’s stock valued at $14,690,000 after purchasing an additional 30,115 shares during the last quarter. Finally, MAI Capital Management raised its position in shares of iShares Biotechnology ETF by 4.2% in the 1st quarter. MAI Capital Management now owns 98,158 shares of the financial services provider’s stock valued at $12,554,000 after purchasing an additional 3,923 shares during the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Down 0.9%

Shares of iShares Biotechnology ETF stock opened at $156.08 on Wednesday. The company has a 50 day moving average price of $147.54 and a 200 day moving average price of $134.95. iShares Biotechnology ETF has a 52 week low of $107.43 and a 52 week high of $159.79.

iShares Biotechnology ETF Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were given a dividend of $0.0828 per share. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.